{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:00:52Z","timestamp":1790283652509,"version":"4.1.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Two patients with different amyotrophic lateral sclerosis (ALS) phenotypes underwent <jats:sup>18<\/jats:sup>F-THK5351 PET to visualize lesions undergoing astrogliosis by measuring monoamine oxidase B activity. Patient 1 was a 57-year-old man with flail leg syndrome. Elevated uptake was observed inside the motor cortex, corresponding to the leg area in a cortical homunculus. Patient 2 was a 64-year-old man with ALS-frontotemporal dementia semantic variant. Elevated uptake was observed around the left anterior temporal lobe. Both core lesions were consistent with their respective neurological features. Hence, <jats:sup>18<\/jats:sup>F-THK5351 PET is a useful technique to assess ALS pathophysiology by visualizing the core lesions.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003755","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T21:07:30Z","timestamp":1623445650000},"page":"e582-e583","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["18F-THK5351 PET Can Identify Core Lesions in Different Amyotrophic Lateral Sclerosis Phenotypes"],"prefix":"10.1097","volume":"46","author":[{"given":"Mana","family":"Higashihara","sequence":"first","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Geriatric Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M.","family":"Tokumaru","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Geriatric Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain","volume":"9","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2967\/jnumed.117.197426","article-title":"Correlations of (18)F-THK5351 PET with postmortem burden of tau and astrogliosis in Alzheimer disease","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/RLU.0000000000002564","article-title":"Monoamine oxidase B binding of 18F-THK5351 to visualize glioblastoma and associated gliosis: an autopsy-confirmed case","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","first-page":"11","article-title":"Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer\u2019s disease","volume":"93","year":"2020","journal-title":"Nucl Med Biol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0306-4522(96)83013-2","article-title":"Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry","volume":"70","year":"1996","journal-title":"Neuroscience"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/RLU.0000000000001868","article-title":"Potential use of 18F-THK5351 PET to identify wallerian degeneration of the pyramidal tract caused by cerebral infarction","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/RLU.0000000000002751","article-title":"18F-THK5351 PET can identify astrogliosis in multiple sclerosis plaques","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12880-020-00481-4","article-title":"Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using (18)F-THK5351 positron emission tomography","volume":"20","year":"2020","journal-title":"BMC Med Imaging"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/RLU.0000000000003197","article-title":"Head-to-head comparison of the two MAO-B radioligands, 18F-THK5351 and 11C-L-Deprenyl, to visualize astrogliosis in patients with neurological disorders","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","article-title":"The phenotypic variability of amyotrophic lateral sclerosis","volume":"10","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresrev.2004.05.003","article-title":"A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis","volume":"47","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00401-019-02077-x","article-title":"The basis of clinicopathological heterogeneity in TDP-43 proteinopathy","volume":"138","year":"2019","journal-title":"Acta Neuropathol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:04:52Z","timestamp":1750536292000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003755","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,11]]}}}